SMPD1 and glioma: Ionizing radiation and TMZ, as current standard therapy for glioma patients, affect the sphingolipid pathway by activating SMPD1 which hydrolyzes sphingomyelin to pro-apoptotic ceramide (Hawkins et al., 2020; Tea et al., 2020).